Study | Diagnosis target | Reference method | Number of subjects (control/patient) | Plethysmography method | Sensitivity | Specificity |
---|---|---|---|---|---|---|
Harada et al. [74] | CVI | Venography | 31a (0/31) | APG | 73% | 100% |
Criado et al. [35] | CVI | Duplex scanning and venography | 186a (61/125) | APG | 80% | 94% |
Bays et al. [50] | CVI | Duplex ultrasound | 20a (10/10) | APG | 70%–100% | 90%–100% |
Rosfors et al. [42] | Venous disorder (CVI, DVT) | Duplex ultrasound | 119 (63/56) | SGP | 96%–98% | Not given |
Allen et al. [48] | PAD | ABI | 107 (63/44) | PPG | 90.6%, | 88.9% |
Ro et al. [49] | PAD | Angiography | 194a (31/163) | PPG | 81.6% | 77.4% |
Bays et al. [50] | CVI | Duplex ultrasound | 20a (10/10) | PPG | 100% | 60% |
Sarin et al. [51] | CVI | Duplex scanning | 304a (80/224) | PPG | 74–79% | 61% |
Mitrani et al. [52] | DVT | Venography | 69 (45/24) | PPG | 83%–96% | 71%–89% |
Arora et al. [53] | DVT | Venography | 69a (41/28) | PPG | 96.4% | 82.9% |
Thomas et al. [54] | DVT | Venography | 131a (61/70) | PPG | 92% | 84% |
Tan et al. [55] | DVT | Venography or duplex | 103a (66/37) | PPG | 100% | 35%–56% |
Anderson [36] | PAD | Angiography | 61a (28/33) | IPG | > 90% | >90% |
Mašanauskienė et al. [61] | PAD | ABI | 62 (21/41) | IPG | 73.2% | 96% |
Hull et al. [64] | DVT | Venography | 200 (114/86) | IPG | 94% | 91% |
Toy et al. [65] | DVT | Venography | 25a (9/16) | IPG | 94% | 100% |
Flanigan et al. [66] | DVT | Venography | 207a (136/71) | IPG | 90.4% | 75.7% |
Cooperman et al. [67] | DVT | Venography | 98a (75/23) | IPG | 87% | 96% |
Liapis et al. [68] | DVT | Venography | 308a (169/139) | IPG | 91% | 89% |
Peters et al. [69] | DVT | Venography | 185 (124/61) | IPG | 84% | 93% |
Cruickshank et al. [70] | DVT | Venography | 1010a (812/198) | IPG | 12.9% | 98.1% |
Paiement et al. [72] | DVT | Venography | 937a (864/73) | IPG | 12.3% | 99.1% |
Agnelli et al. [73] | DVT | Venography | 440a (295/145) | IPG | 19% | 91% |